Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
1997-1-13
pubmed:abstractText
The purpose of this study was to compare and evaluate sedation with intravenous xylazine (1.1 mg/kg bodyweight [BW]) versus intravenous romifidine (100 micrograms/kg BW) followed by induction of anesthesia with intravenous diazepam (0.04 mg/kg BW) and ketamine (2.2 mg/kg BW). Twelve healthy horses were used in a blinded, randomized, cross-over design. Heart rate, presence of 2nd degree atrioventricular heart blocks (2 degrees AVB), respiratory rate, arterial blood pressures, blood gases, packed cell volume, total serum proteins, and duration of anesthesia and recumbency were recorded. Induction and recovery quality was evaluated using a 0 to 4 score. Response to stimulation with noise, pressure, and cutaneous electrical stimulation was assessed at 5 minute intervals during recumbency to evaluate the depth of anesthesia. Heart rate was lower and 2 degrees AVB more frequent in the romifidine group, while blood pressure was lower in the xylazine group. Duration of anesthesia was longer in the romifidine group (mean 20.8, s mean 2.3 min) versus the xylazine group (mean 15.8, s mean 1.6 min), while induction and recovery were excellent in both groups. Respiratory rates, blood gas values, packed cell volumes, and total protein levels did not differ between groups. The results indicate that romifidine premedication followed by diazepam and ketamine is a very satisfactory regime for short duration intravenous anesthesia in horses.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/8896874-1190582, http://linkedlifedata.com/resource/pubmed/commentcorrection/8896874-1359161, http://linkedlifedata.com/resource/pubmed/commentcorrection/8896874-1455641, http://linkedlifedata.com/resource/pubmed/commentcorrection/8896874-1502994, http://linkedlifedata.com/resource/pubmed/commentcorrection/8896874-1854087, http://linkedlifedata.com/resource/pubmed/commentcorrection/8896874-1901788, http://linkedlifedata.com/resource/pubmed/commentcorrection/8896874-1949566, http://linkedlifedata.com/resource/pubmed/commentcorrection/8896874-2124750, http://linkedlifedata.com/resource/pubmed/commentcorrection/8896874-2267414, http://linkedlifedata.com/resource/pubmed/commentcorrection/8896874-2392824, http://linkedlifedata.com/resource/pubmed/commentcorrection/8896874-249147, http://linkedlifedata.com/resource/pubmed/commentcorrection/8896874-2575673, http://linkedlifedata.com/resource/pubmed/commentcorrection/8896874-2729719, http://linkedlifedata.com/resource/pubmed/commentcorrection/8896874-3464175, http://linkedlifedata.com/resource/pubmed/commentcorrection/8896874-3464177, http://linkedlifedata.com/resource/pubmed/commentcorrection/8896874-3464178, http://linkedlifedata.com/resource/pubmed/commentcorrection/8896874-3555725, http://linkedlifedata.com/resource/pubmed/commentcorrection/8896874-3589163, http://linkedlifedata.com/resource/pubmed/commentcorrection/8896874-3590553, http://linkedlifedata.com/resource/pubmed/commentcorrection/8896874-4875426, http://linkedlifedata.com/resource/pubmed/commentcorrection/8896874-4938478, http://linkedlifedata.com/resource/pubmed/commentcorrection/8896874-5014460, http://linkedlifedata.com/resource/pubmed/commentcorrection/8896874-5349241, http://linkedlifedata.com/resource/pubmed/commentcorrection/8896874-6734582, http://linkedlifedata.com/resource/pubmed/commentcorrection/8896874-6808866, http://linkedlifedata.com/resource/pubmed/commentcorrection/8896874-697134, http://linkedlifedata.com/resource/pubmed/commentcorrection/8896874-7029871, http://linkedlifedata.com/resource/pubmed/commentcorrection/8896874-7149375, http://linkedlifedata.com/resource/pubmed/commentcorrection/8896874-7257099, http://linkedlifedata.com/resource/pubmed/commentcorrection/8896874-8337799, http://linkedlifedata.com/resource/pubmed/commentcorrection/8896874-842917
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0008-5286
pubmed:author
pubmed:issnType
Print
pubmed:volume
37
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
601-9
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:8896874-Adjuvants, Anesthesia, pubmed-meshheading:8896874-Anesthesia, pubmed-meshheading:8896874-Anesthetics, pubmed-meshheading:8896874-Anesthetics, Dissociative, pubmed-meshheading:8896874-Animals, pubmed-meshheading:8896874-Blood Gas Analysis, pubmed-meshheading:8896874-Blood Pressure, pubmed-meshheading:8896874-Blood Proteins, pubmed-meshheading:8896874-Cross-Over Studies, pubmed-meshheading:8896874-Diazepam, pubmed-meshheading:8896874-Double-Blind Method, pubmed-meshheading:8896874-Drug Combinations, pubmed-meshheading:8896874-Female, pubmed-meshheading:8896874-Heart Rate, pubmed-meshheading:8896874-Horses, pubmed-meshheading:8896874-Imidazoles, pubmed-meshheading:8896874-Injections, Intravenous, pubmed-meshheading:8896874-Ketamine, pubmed-meshheading:8896874-Male, pubmed-meshheading:8896874-Time Factors, pubmed-meshheading:8896874-Xylazine
pubmed:year
1996
pubmed:articleTitle
A comparison of romifidine and xylazine when used with diazepam/ketamine for short duration anesthesia in the horse.
pubmed:affiliation
Department of Clinical Studies, Ontario Veterinary College, University of Guelph.
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't